Letter | Published:

A Possible Mode of Action of ‘Paludrine’

Nature volume 158, pages 707708 (16 November 1946) | Download Citation

Subjects

Abstract

IN the evolution of the antimalarial drug ‘Paludrine’, the diguanide system was selected because it provided structural features similar to those found in the earlier active pyrimidine compound ‘2666’1. The biochemistry of the former drug, together with the results obtained in both experimental and clinical therapy, indicate, however, that it is biologically distinct from the prototype molecule. Thus, for example, therapeutic potency is many times greater, and is apparent not only against the erythrocytic but also against the exo-erythrocytic forms of the malaria parasite. Further, ‘Paludrine’ does not show the antagonism for riboflavine exhibited by ‘2666’ (and mepacrine) with respect to the growth of the Lactobacillus casei, an effect that we associate with the formal structural resemblance of the latter drugs to the vitamin, and which may also be connected with their parasiticidal activity.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , and , Ann. Trop. Med. and Parasitol., 39, 208 (1945).

Download references

Author information

Affiliations

  1. Research Laboratories, Imperial Chemical Industries, Ltd., Manchester, 9. Oct. 11.

    • F. H. S. CURD
    •  & F. L. ROSE

Authors

  1. Search for F. H. S. CURD in:

  2. Search for F. L. ROSE in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/158707b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.